Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › antibiotic-associated diarrhea

Antibiotic-associated diarrhea

3 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for antibiotic-associated diarrhea

5 trials tracked for antibiotic-associated diarrhea: 2 in phase 3 or 4.

5Trials tracked
2Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 3 2 Phase 2 1 Phase 1 2
  1. Phase 3 Study of LRG-002 Hard Capsules (Lek d.d., Slovenia) Used in the Prophylaxis of Antibiotic-associated Diarrhea in Adults. Completed
  2. Phase 3 Efficacy and Safety Study in the Prevention of Antibiotic-Associated Diarrhea (AAD) and Clostridium Difficile-Associated Diarrhea (CDAD) in Hospitalized Adult Patients Exposed to Nosocomial Infection Completed
  3. Phase 2 Efficacy and Safety of BB-12 Supplemented Strawberry Yogurt For Healthy Children on Antibiotics Completed
  4. Phase 1 Mechanisms of Preventing Antibiotic-Associated Diarrhea and the Role for Probiotics Completed
  5. Phase 1 Mechanisms of Probiotics and Antibiotic-Associated Diarrhea Completed

Showing the 5 most-cited and recently-updated of 5 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Meta-analysis finds Bacillus subtilis and Enterococcus faecium reduce antibiotic-associated diarrhea
Infectious Disease Meta-analysis
Meta-analysis finds Bacillus subtilis and Enterococcus faecium reduce antibiotic-associated diarrhea A Common Probiotic Cuts Antibiotic Diarrhea Risk By 70 Percent
This RCT-based meta-analysis evaluated live combined Bacillus subtilis and Enterococcus faecium (LCBE) plus symptomatic therapy versus sympt…
A specific probiotic blend cuts antibiotic-linked diarrhea risk by over 70 percent and speeds recovery for both children and adults.
May 14, 2026
Literature review synthesizes Schisandra chinensis effects on gut microbiota and metabolic pathways across multiple conditions
Gastroenterology Sys. Review
Literature review synthesizes Schisandra chinensis effects on gut microbiota and metabolic pathways across multiple conditions This Ancient Berry May Quiet Inflammation From Your Gut to Your Brain
This literature review examines the potential of Schisandra chinensis regarding gut health and metabolic regulation.
An ancient berry used for centuries may rebalance gut bacteria to calm inflammation linked to digestive issues, liver disease, diabetes, and…
Frontiers Apr 19, 2026
Antibiotic use and risk factors linked to AAD and CDAD in critically ill patients
Infectious Disease Meta-analysis
Antibiotic use and risk factors linked to AAD and CDAD in critically ill patients Nearly 1 in 3 ICU Patients Get Antibiotic Diarrhea, New Analysis Finds
This systematic review and meta-analysis evaluated the incidence of antibiotic-associated diarrhea (AAD) and Clostridioides difficile-associ…
Nearly 1 in 3 critically ill patients develop antibiotic diarrhea, a common side effect that delays recovery and affects older adults and di…
Apr 15, 2026